Ever imagine what the impact of misidentifying the correct mutation could be on cancer or missing critical information in your research? What would be the impact to a child fighting with cancer or a loved one not getting the right treatment at the right time? What would the impact of missing an already identified variant be on your research? These questions are best left unanswered by choosing to work with only the best and most comprehensive database for human cancer mutations.
With over 71 million somatic mutations, COSMIC is the world’s largest expert-curated somatic mutation database. Trusted by over >20.000 users, it is integral to any clinical assessment of somatic variants. Integrating COSMIC into your NGS pipeline accelerates cancer sample analysis by rapidly prioritizing cancer driver mutations, distinguishing VUSes, and determining if an alteration is common or rare in the cancer type of interest.
Empower your research and diagnosis with the world’s largest database of human cancer mutations
with well over 20,000 users and in excess of 10,000 citations
All data has been manually curated, standardized and evaluated for accuracy from peer-reviewed papers by a team of postdoctoral scientists.
COSMIC provides genome wide annotation with over 37 million coding mutations plus substantial coverage of all other oncogenic non-coding regions.
Every four months, COSMIC content and features are updated to ensure you remain informed on the latest findings.
COSMIC is constantly being updated with the latest information on cancer mutations. With over 5,000,000 coding mutations added in 2019 to 2020, almost double the coding mutations that have been collected over the past 15 years.
Attend this insightful webinar if you want to know all about COSMIC and its hand curated content, Actionability – it’s latest offering on drugs that target specific somatic mutations and much more!
On March 24, COSMIC released Actionability which is aimed to indicate the availability of drugs that target mutations in cancer and track the progress of clinical studies towards making new drugs available. Drugs that target somatic mutations are represented at all stages of drug development, through safety and clinical phases to market and repurposing, with additional case studies.
Identifying and studying actionable variants is of great interest to many investigators.
Watch this webinar recording, where COSMIC, HGMD and QIAGEN Knowledge Base is introduced for annotation and investigation of both somatic and germline variants.
COSMIC has been fueling cancer research for the past 15 years. From its humble beginnings see how this knowledge base plays its part in the fight against cancer and making a difference in patient care.
Expand your clinical interpretation with expert-curated software for variant classification of any assay, covering any indication, on your sequencing platform
Reimagine your clinical interpretation with same day, expert variant classification services tailored to your oncology panel
Leverage the benefits of automation and expert support to improve test turnaround times and clinical reporting capabilities